Sarepta Therapeutics, Inc. SRPT Increase Decrease In Manufacturing Related Deposits And Prepaids
Increase Decrease In Manufacturing Related Deposits And Prepaids at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:IncreaseDecreaseInManufacturingRelatedDepositsAndPrepaids.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s increase decrease in manufacturing related deposits and prepaids.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s increase decrease in manufacturing related deposits and prepaids?
- Sarepta Therapeutics, Inc. (SRPT) reported increase decrease in manufacturing related deposits and prepaids of -$43.49M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s increase decrease in manufacturing related deposits and prepaids changed year-over-year?
- Sarepta Therapeutics, Inc.'s increase decrease in manufacturing related deposits and prepaids increased by 38.9% year-over-year, from -$71.14M to -$43.49M.
- What does increase decrease in manufacturing related deposits and prepaids mean?
- Tracks the change in cash outflows for deposits and prepayments made to vendors for manufacturing services or raw materials. A significant increase indicates rising upfront commitments to secure production capacity or supply chain stability.